Is skipping 'natty' and jumping on AAS really the smarter move?
Quick answer
Testosterone replacement therapy is an FDA-regulated treatment for hypogonadism, defined clinically as consistently low serum testosterone with accompanying symptoms. Supraphysiologic androgen use in eugonadal individuals is distinct from TRT and carries documented cardiovascular, reproductive, and endocrine risks that scale with dose and duration. Unsupervised cycling without baseline labs, monitoring, or post-cycle evaluation is outside any recognized standard of care.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and hashtags, @hagotren is making a case that staying natural is a waste of time and that a 3-month anabolic-androgenic steroid (AAS) cycle produces results that natural training simply cannot match. The phrase "pin to win" is standard AAS community shorthand for injectable testosterone or other compounds. The TRT hashtag alongside #aas suggests the creator may be blurring the line between legitimate testosterone replacement therapy, which is a medically supervised treatment for clinically low testosterone, and performance-enhancing steroid use in otherwise healthy, eugonadal men. That conflation is worth paying attention to, because they are not the same thing clinically, legally, or physiologically. The framing of "natty is cope" positions natural training as irrational rather than simply a different risk-benefit calculation, which is a rhetorical move, not a scientific argument.
What does the science actually show?
Supraphysiologic testosterone does produce substantial muscle and strength gains. Bhasin et al. (1996, NEJM) is the landmark reference here: men given 600mg testosterone enanthate weekly for 10 weeks without training gained roughly 3.2kg of lean mass, while trained men on the same dose gained about 6.1kg. That is real. Nobody serious disputes that exogenous androgens accelerate hypertrophy. However, the same body of literature documents real risks. A 2017 study by Baggish et al. in Circulation found that long-term AAS users had significantly reduced left ventricular function and lower HDL cholesterol compared to age-matched controls, with some damage persisting years after cessation. Rahnema et al. (2014, Fertility and Sterility) documented that exogenous androgen use suppresses the hypothalamic-pituitary-gonadal axis and can cause prolonged or permanent hypogonadism post-cycle. The "3-month cycle" framing glosses over all of this.
Where does the social media noise diverge from clinical reality?
The TikTok AAS community consistently treats TRT dosing as a spectrum that conveniently includes performance doses. Clinically, TRT targets a serum testosterone level in the normal physiologic range, typically 400-700 ng/dL, using doses like 100-200mg testosterone cypionate or enanthate weekly depending on individual response. What gets called a "beginner cycle" in these videos, often 300-500mg weekly or more, produces supraphysiologic levels that no legitimate TRT protocol is targeting. The distinction matters because the cardiovascular and endocrine risks are dose-dependent. Shabir et al. (2023, European Heart Journal) reinforced that AAS-related cardiomyopathy risk scales with cumulative dose and duration. Beyond cardiology, the normalization of unsupervised cycling, including PCT protocols discussed without bloodwork or physician oversight, represents a genuine harm-reduction gap that these videos do not address. "Pin to win" is a vibe, not a protocol.
What should you actually know?
If you have clinically confirmed hypogonadism, diagnosed with two fasting morning testosterone draws below the lab reference range plus symptoms, TRT under medical supervision is a legitimate, evidence-supported treatment. That is not what this video is advocating. What it is advocating is elective supraphysiologic androgen use in presumably healthy young men, which carries measurable cardiovascular, reproductive, and psychological risks. Natural resistance training, while slower, does produce meaningful hypertrophy. A 2022 meta-analysis by Lim et al. in Sports Medicine found natural trainees accumulate roughly 1-2kg of lean mass per month under optimized conditions in early training. That is not zero. The risk-benefit math on AAS is genuinely personal, but it should be made with accurate information, not influencer bravado. Anyone considering exogenous androgens should have baseline bloodwork, cardiac screening, and an actual physician involved, not a comment section.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Is skipping 'natty' and jumping on AAS really the smarter move?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Is skipping 'natty' and jumping on AAS really the smarter move? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy is an FDA-regulated treatment for hypogonadism, defined clinically as consistently low serum testosterone with accompanying symptoms.
FormBlends verdict
Testosterone replacement therapy is an FDA-regulated treatment for hypogonadism, defined clinically as consistently low serum testosterone with accompanying symptoms. Supraphysiologic androgen use in eugonadal individuals is distinct from TRT and carries documented cardiovascular, reproductive, and endocrine risks that scale with dose and duration. Unsupervised cycling without baseline labs, monitoring, or post-cycle evaluation is outside any recognized standard of care.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy is an FDA-regulated treatment for hypogonadism, defined clinically as consistently low serum testosterone with accompanying symptoms. Supraphysiologic androgen use in eugonadal individuals is distinct from TRT and carries documented cardiovascular, reproductive, and endocrine risks that scale with dose and duration. Unsupervised cycling without baseline labs, monitoring, or post-cycle evaluation is outside any recognized standard of care.
- Supraphysiologic testosterone does accelerate muscle gain, but the NEJM reference everyone cites also involved medical supervision and baseline health screening that most self-administered cycles lack.
- TRT is a treatment for a diagnosed medical condition targeting normal physiologic testosterone levels, not a synonym for performance AAS use at higher doses.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Supraphysiologic testosterone does accelerate muscle gain, but the NEJM reference everyone cites also involved medical supervision and baseline health screening that most self-administered cycles lack.
- TRT is a treatment for a diagnosed medical condition targeting normal physiologic testosterone levels, not a synonym for performance AAS use at higher doses.
- Long-term AAS users show measurably reduced left ventricular function and HDL cholesterol compared to age-matched controls, with some cardiovascular changes persisting after cessation.
- Exogenous androgen use suppresses the hypothalamic-pituitary-gonadal axis and can cause prolonged hypogonadism post-cycle, including in men who started with normal testosterone levels.
- Natural resistance training under optimized conditions produces approximately 1-2kg of lean mass per month in early training phases, which is not zero.
- Anyone seriously evaluating exogenous androgens should obtain baseline bloodwork including total and free testosterone, hematocrit, lipid panel, and cardiac evaluation before starting.
- The hashtag conflation of #trt and #aas in performance content is a recognized pattern that regulators and harm-reduction researchers have flagged for normalizing unsupervised hormone use.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
hago · TikTok creator
13.5K views on this video
3 month cycle > your natty obsession. NATTY IS COPE. pin to win. stop waiting. Stop waisting time. #aas #natty #pharmacology #trt #transformation
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by hago, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.